SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 210.16 |
Enterprise Value ($M) | 188.96 |
Book Value ($M) | 277.69 |
Book Value / Share | 4.92 |
Price / Book | 0.76 |
NCAV ($M) | 272.63 |
NCAV / Share | 4.83 |
Price / NCAV | 0.77 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.24 |
Return on Assets (ROA) | -0.21 |
Return on Equity (ROE) | -0.21 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 29.58 |
Current Ratio | 29.58 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 284.58 |
Assets | 289.64 |
Liabilities | 11.96 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -78.19 |
Net Income | -66.86 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -58.56 |
Cash from Investing | 52.54 |
Cash from Financing | 0.72 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
13G/A | Citadel Advisors Llc | 3.30 | ||
13G/A | State Street Corp | 1.24 | -77.11 | |
13G/A | Ra Capital Management, L.p. | 0.00 | -100.00 | |
13G/A | BlackRock Inc. | 4.30 | -31.74 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
19,276 | 120,189 | 16.04 | |
16,652 | 173,975 | 9.57 | |
12,524 | 44,533 | 28.12 | |
(click for more detail) |
Similar Companies | |
---|---|
DAWN – Day One Biopharmaceuticals, Inc. | DCPH – Deciphera Pharmaceuticals, Inc. |
DNLI – Denali Therapeutics Inc. | DVAX – Dynavax Technologies Corporation |
EDIT – Editas Medicine, Inc. |
Financial data and stock pages provided by
Fintel.io